Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.41743986 |
2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.41743986 |
3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.23638626 |
4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.63894623 |
5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.07185077 |
6 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.59819214 |
7 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.35158007 |
8 | positive regulation of B cell differentiation (GO:0045579) | 4.18844995 |
9 | immunoglobulin mediated immune response (GO:0016064) | 4.18780485 |
10 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.08381330 |
11 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.91748923 |
12 | regulation of B cell differentiation (GO:0045577) | 3.81578653 |
13 | ribosomal small subunit assembly (GO:0000028) | 3.71766028 |
14 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.71622068 |
15 | detection of bacterium (GO:0016045) | 3.62899434 |
16 | response to peptidoglycan (GO:0032494) | 3.62061046 |
17 | mast cell activation (GO:0045576) | 3.60004863 |
18 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.59199608 |
19 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.58503063 |
20 | myeloid dendritic cell activation (GO:0001773) | 3.56982375 |
21 | detection of other organism (GO:0098543) | 3.56839033 |
22 | response to type I interferon (GO:0034340) | 3.55590986 |
23 | cellular response to type I interferon (GO:0071357) | 3.55500301 |
24 | type I interferon signaling pathway (GO:0060337) | 3.55500301 |
25 | B cell mediated immunity (GO:0019724) | 3.51782584 |
26 | NIK/NF-kappaB signaling (GO:0038061) | 3.49079775 |
27 | B cell receptor signaling pathway (GO:0050853) | 3.47682321 |
28 | regulation of gamma-delta T cell activation (GO:0046643) | 3.46785658 |
29 | negative regulation of phagocytosis (GO:0050765) | 3.46217732 |
30 | negative thymic T cell selection (GO:0045060) | 3.45021461 |
31 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.43476974 |
32 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.40258433 |
33 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.39072114 |
34 | positive regulation of granulocyte differentiation (GO:0030854) | 3.38047460 |
35 | negative T cell selection (GO:0043383) | 3.37314525 |
36 | positive regulation of tolerance induction (GO:0002645) | 3.36663357 |
37 | myeloid dendritic cell differentiation (GO:0043011) | 3.27456157 |
38 | response to interleukin-15 (GO:0070672) | 3.26688362 |
39 | positive regulation of antigen processing and presentation (GO:0002579) | 3.26019777 |
40 | regulation of tolerance induction (GO:0002643) | 3.24516911 |
41 | leukocyte aggregation (GO:0070486) | 3.22764894 |
42 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.21968507 |
43 | tolerance induction (GO:0002507) | 3.21567389 |
44 | T cell selection (GO:0045058) | 3.19897279 |
45 | positive regulation of interferon-alpha production (GO:0032727) | 3.19175890 |
46 | defense response to protozoan (GO:0042832) | 3.18923547 |
47 | response to protozoan (GO:0001562) | 3.18415449 |
48 | regulation of germinal center formation (GO:0002634) | 3.17776023 |
49 | cellular response to zinc ion (GO:0071294) | 3.16983410 |
50 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.16863113 |
51 | T cell migration (GO:0072678) | 3.16212955 |
52 | positive T cell selection (GO:0043368) | 3.15076915 |
53 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.14501595 |
54 | * response to interferon-beta (GO:0035456) | 3.14393379 |
55 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.13827767 |
56 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.11670641 |
57 | neutrophil activation involved in immune response (GO:0002283) | 3.06154269 |
58 | regulation of interferon-alpha production (GO:0032647) | 3.04394590 |
59 | T cell homeostasis (GO:0043029) | 3.03996446 |
60 | interferon-gamma production (GO:0032609) | 3.03934286 |
61 | negative regulation of T cell mediated immunity (GO:0002710) | 3.03791072 |
62 | mature B cell differentiation (GO:0002335) | 3.00845163 |
63 | definitive hemopoiesis (GO:0060216) | 3.00561331 |
64 | pinocytosis (GO:0006907) | 2.99845947 |
65 | positive thymic T cell selection (GO:0045059) | 2.97882129 |
66 | viral transcription (GO:0019083) | 2.95816172 |
67 | regulation of antigen processing and presentation (GO:0002577) | 2.95464961 |
68 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.94474786 |
69 | mature B cell differentiation involved in immune response (GO:0002313) | 2.93610964 |
70 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.93379338 |
71 | * cellular response to interferon-beta (GO:0035458) | 2.91745186 |
72 | positive regulation of isotype switching (GO:0045830) | 2.90847404 |
73 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.89331152 |
74 | dendritic cell differentiation (GO:0097028) | 2.87772005 |
75 | regulation of mast cell degranulation (GO:0043304) | 2.86293483 |
76 | Peyers patch development (GO:0048541) | 2.85947084 |
77 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.85947084 |
78 | positive regulation of macrophage differentiation (GO:0045651) | 2.84613831 |
79 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.84230220 |
80 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.84230220 |
81 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.84230220 |
82 | modulation by symbiont of host immune response (GO:0052553) | 2.84230220 |
83 | positive regulation by symbiont of host defense response (GO:0052509) | 2.84230220 |
84 | modulation by symbiont of host defense response (GO:0052031) | 2.84230220 |
85 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.84201996 |
86 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.84201996 |
87 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.83758220 |
88 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.83741315 |
89 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.81789857 |
90 | negative regulation of interleukin-6 production (GO:0032715) | 2.81750137 |
91 | regulation of T cell tolerance induction (GO:0002664) | 2.81618024 |
92 | regulation of necroptotic process (GO:0060544) | 2.81075829 |
93 | translational termination (GO:0006415) | 2.80189980 |
94 | negative regulation of innate immune response (GO:0045824) | 2.80007718 |
95 | respiratory burst (GO:0045730) | 2.79631998 |
96 | mast cell degranulation (GO:0043303) | 2.79536986 |
97 | mast cell activation involved in immune response (GO:0002279) | 2.79536986 |
98 | regulation of granulocyte differentiation (GO:0030852) | 2.78832465 |
99 | angiogenesis involved in wound healing (GO:0060055) | 2.77522316 |
100 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.77160605 |
101 | cellular response to interleukin-15 (GO:0071350) | 2.76806728 |
102 | mannose metabolic process (GO:0006013) | 2.76190265 |
103 | germinal center formation (GO:0002467) | 2.75851889 |
104 | lymphocyte homeostasis (GO:0002260) | 2.75030970 |
105 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.73674398 |
106 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.73447272 |
107 | myeloid cell activation involved in immune response (GO:0002275) | 2.73211006 |
108 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.73207900 |
109 | response to muramyl dipeptide (GO:0032495) | 2.72792340 |
110 | lymph node development (GO:0048535) | 2.70966956 |
111 | negative regulation of granulocyte differentiation (GO:0030853) | 2.70889971 |
112 | negative regulation of interleukin-8 production (GO:0032717) | 2.70760860 |
113 | leukocyte degranulation (GO:0043299) | 2.70430242 |
114 | negative regulation of interleukin-12 production (GO:0032695) | 2.69705786 |
115 | neutrophil activation (GO:0042119) | 2.67890217 |
116 | regulation of leukocyte degranulation (GO:0043300) | 2.67759964 |
117 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.67194554 |
118 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.66983207 |
119 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.66607635 |
120 | thymic T cell selection (GO:0045061) | 2.66535497 |
121 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.66299892 |
122 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.65924126 |
123 | negative regulation of cell killing (GO:0031342) | 2.65924126 |
124 | detection of external biotic stimulus (GO:0098581) | 2.65759224 |
125 | regulation of response to interferon-gamma (GO:0060330) | 2.65326140 |
126 | response to interferon-alpha (GO:0035455) | 2.65254843 |
127 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.62747668 |
128 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.62747668 |
129 | leukocyte homeostasis (GO:0001776) | 2.59888149 |
130 | cellular extravasation (GO:0045123) | 2.59371452 |
131 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.59126121 |
132 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.58540807 |
133 | macrophage activation involved in immune response (GO:0002281) | 2.58183463 |
134 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.57879848 |
135 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.57879848 |
136 | actin nucleation (GO:0045010) | 2.57314925 |
137 | regulation of regulatory T cell differentiation (GO:0045589) | 2.57084334 |
138 | natural killer cell activation (GO:0030101) | 2.57070856 |
139 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.56771806 |
140 | axonemal dynein complex assembly (GO:0070286) | 2.55733871 |
141 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.55310608 |
142 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.54861716 |
143 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.53102230 |
144 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.52817939 |
145 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.51414718 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.94782127 |
2 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.45410949 |
3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.36854875 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.92889124 |
5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.89883390 |
6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.69097684 |
7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.40479798 |
8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.37746359 |
9 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.12590917 |
10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.01696667 |
11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.82549207 |
12 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.73588498 |
13 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.72892686 |
14 | MYC_22102868_ChIP-Seq_BL_Human | 2.70373923 |
15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.66881852 |
16 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.63147053 |
17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.61077036 |
18 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.57519626 |
19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.55894965 |
20 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.54626502 |
21 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.53798976 |
22 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.46287231 |
23 | * MYB_26560356_Chip-Seq_TH2_Human | 2.43673085 |
24 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.37738412 |
25 | MAF_26560356_Chip-Seq_TH1_Human | 2.31691204 |
26 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.21954982 |
27 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.09402498 |
28 | MYB_26560356_Chip-Seq_TH1_Human | 2.09371560 |
29 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.08093434 |
30 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.05550954 |
31 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.04755913 |
32 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.04647755 |
33 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.04603203 |
34 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.98997306 |
35 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.97718691 |
36 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.96798856 |
37 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.96307950 |
38 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.94283180 |
39 | UTX_26944678_Chip-Seq_JUKART_Human | 1.85602474 |
40 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.79219848 |
41 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.76576064 |
42 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75345758 |
43 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74911397 |
44 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.66223592 |
45 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.63381677 |
46 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.62763650 |
47 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.62654610 |
48 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.57048659 |
49 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.55971576 |
50 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53738059 |
51 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.53434119 |
52 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.52935266 |
53 | SPI1_23127762_ChIP-Seq_K562_Human | 1.52413673 |
54 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.45276322 |
55 | GATA1_19941826_ChIP-Seq_K562_Human | 1.45033931 |
56 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.44976043 |
57 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.43985465 |
58 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.43973022 |
59 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.43796372 |
60 | MAF_26560356_Chip-Seq_TH2_Human | 1.43014082 |
61 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.41087397 |
62 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.40168967 |
63 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.39693681 |
64 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.38094801 |
65 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.35618115 |
66 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.35268106 |
67 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.33366088 |
68 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.31187230 |
69 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.31103736 |
70 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.30671798 |
71 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.27364689 |
72 | GATA1_22025678_ChIP-Seq_K562_Human | 1.27113050 |
73 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.26974920 |
74 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.26595612 |
75 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.25448797 |
76 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.21211399 |
77 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.21057147 |
78 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.20716002 |
79 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.20511591 |
80 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.20477263 |
81 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17939240 |
82 | P68_20966046_ChIP-Seq_HELA_Human | 1.16312471 |
83 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.15351042 |
84 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.14364449 |
85 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.12886746 |
86 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.12221507 |
87 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.11914087 |
88 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08968510 |
89 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08884574 |
90 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08815283 |
91 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.07791730 |
92 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.06223003 |
93 | GATA3_26560356_Chip-Seq_TH2_Human | 1.04653325 |
94 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.03145732 |
95 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.02460702 |
96 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.02376401 |
97 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.01958865 |
98 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01843466 |
99 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.01755765 |
100 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.00861058 |
101 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.00080760 |
102 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.98688461 |
103 | P300_27268052_Chip-Seq_Bcells_Human | 0.96716262 |
104 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.96715206 |
105 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.96152013 |
106 | GATA2_19941826_ChIP-Seq_K562_Human | 0.95835016 |
107 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95553407 |
108 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.94928626 |
109 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94881813 |
110 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.94449857 |
111 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94266612 |
112 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.92651204 |
113 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.92587171 |
114 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92482351 |
115 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.91126317 |
116 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.90641335 |
117 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90612785 |
118 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.90596042 |
119 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.90369897 |
120 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.89465628 |
121 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88830083 |
122 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.88687659 |
123 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.87256653 |
124 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.83163894 |
125 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.82665108 |
126 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82575019 |
127 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.80788814 |
128 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80342096 |
129 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.77079582 |
130 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.75937809 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 4.74020987 |
2 | MP0005671_abnormal_response_to | 3.58551394 |
3 | MP0000685_abnormal_immune_system | 3.55991312 |
4 | MP0009785_altered_susceptibility_to | 3.10963578 |
5 | MP0002396_abnormal_hematopoietic_system | 3.08454858 |
6 | MP0001800_abnormal_humoral_immune | 2.97844639 |
7 | MP0003763_abnormal_thymus_physiology | 2.92774480 |
8 | MP0003436_decreased_susceptibility_to | 2.90593686 |
9 | MP0005387_immune_system_phenotype | 2.86263840 |
10 | MP0001790_abnormal_immune_system | 2.86263840 |
11 | MP0005000_abnormal_immune_tolerance | 2.85474007 |
12 | MP0002452_abnormal_antigen_presenting | 2.74697319 |
13 | MP0002148_abnormal_hypersensitivity_rea | 2.71315094 |
14 | * MP0005025_abnormal_response_to | 2.70467441 |
15 | MP0002723_abnormal_immune_serum | 2.65491511 |
16 | MP0002420_abnormal_adaptive_immunity | 2.60251728 |
17 | MP0001819_abnormal_immune_cell | 2.58347450 |
18 | MP0003724_increased_susceptibility_to | 2.49805248 |
19 | * MP0002419_abnormal_innate_immunity | 2.46360583 |
20 | MP0002398_abnormal_bone_marrow | 2.37395601 |
21 | MP0002166_altered_tumor_susceptibility | 2.34829026 |
22 | MP0006082_CNS_inflammation | 2.20029648 |
23 | MP0009333_abnormal_splenocyte_physiolog | 2.17940797 |
24 | MP0000716_abnormal_immune_system | 2.17889861 |
25 | MP0003303_peritoneal_inflammation | 2.17558288 |
26 | MP0001853_heart_inflammation | 2.10266500 |
27 | MP0005464_abnormal_platelet_physiology | 2.07741235 |
28 | MP0002405_respiratory_system_inflammati | 2.07154475 |
29 | MP0001873_stomach_inflammation | 2.01005216 |
30 | MP0000689_abnormal_spleen_morphology | 2.00667985 |
31 | MP0010155_abnormal_intestine_physiology | 2.00507592 |
32 | MP0002722_abnormal_immune_system | 1.93775111 |
33 | MP0002006_tumorigenesis | 1.93117826 |
34 | MP0004808_abnormal_hematopoietic_stem | 1.91200362 |
35 | MP0002429_abnormal_blood_cell | 1.86829607 |
36 | MP0001845_abnormal_inflammatory_respons | 1.74133834 |
37 | MP0003300_gastrointestinal_ulcer | 1.71986439 |
38 | MP0005397_hematopoietic_system_phenotyp | 1.70628412 |
39 | MP0001545_abnormal_hematopoietic_system | 1.70628412 |
40 | MP0000465_gastrointestinal_hemorrhage | 1.64879942 |
41 | MP0003866_abnormal_defecation | 1.63339383 |
42 | MP0000703_abnormal_thymus_morphology | 1.62465732 |
43 | MP0004947_skin_inflammation | 1.57660048 |
44 | MP0000490_abnormal_crypts_of | 1.55371051 |
45 | MP0004510_myositis | 1.55097954 |
46 | MP0001533_abnormal_skeleton_physiology | 1.53668278 |
47 | MP0000858_altered_metastatic_potential | 1.47835931 |
48 | MP0002933_joint_inflammation | 1.38854812 |
49 | MP0008469_abnormal_protein_level | 1.37220141 |
50 | MP0009278_abnormal_bone_marrow | 1.35922190 |
51 | MP0005310_abnormal_salivary_gland | 1.35465227 |
52 | MP0005058_abnormal_lysosome_morphology | 1.32562214 |
53 | MP0006054_spinal_hemorrhage | 1.28514213 |
54 | MP0008007_abnormal_cellular_replicative | 1.27788768 |
55 | MP0001958_emphysema | 1.25575898 |
56 | MP0003448_altered_tumor_morphology | 1.24735097 |
57 | MP0005164_abnormal_response_to | 1.22329589 |
58 | MP0003806_abnormal_nucleotide_metabolis | 1.20631064 |
59 | MP0008260_abnormal_autophagy | 1.17679351 |
60 | MP0008438_abnormal_cutaneous_collagen | 1.17438173 |
61 | MP0003191_abnormal_cellular_cholesterol | 1.15382642 |
62 | MP0000343_altered_response_to | 1.14935453 |
63 | MP0003172_abnormal_lysosome_physiology | 1.13733242 |
64 | MP0005075_abnormal_melanosome_morpholog | 1.13244733 |
65 | MP0004883_abnormal_blood_vessel | 1.11300885 |
66 | MP0005174_abnormal_tail_pigmentation | 1.10256546 |
67 | MP0001542_abnormal_bone_strength | 1.05601979 |
68 | MP0002019_abnormal_tumor_incidence | 1.04037503 |
69 | MP0005165_increased_susceptibility_to | 1.03909567 |
70 | MP0003693_abnormal_embryo_hatching | 1.03438149 |
71 | MP0001851_eye_inflammation | 1.01421846 |
72 | MP0009764_decreased_sensitivity_to | 0.98288196 |
73 | MP0010352_gastrointestinal_tract_polyps | 0.97346355 |
74 | MP0010094_abnormal_chromosome_stability | 0.90076231 |
75 | MP0003656_abnormal_erythrocyte_physiolo | 0.87380584 |
76 | MP0003828_pulmonary_edema | 0.86574338 |
77 | MP0003077_abnormal_cell_cycle | 0.86214233 |
78 | MP0005023_abnormal_wound_healing | 0.83789247 |
79 | MP0005503_abnormal_tendon_morphology | 0.83284670 |
80 | MP0005451_abnormal_body_composition | 0.83052686 |
81 | MP0000681_abnormal_thyroid_gland | 0.81734477 |
82 | MP0000249_abnormal_blood_vessel | 0.77930326 |
83 | MP0002095_abnormal_skin_pigmentation | 0.77600855 |
84 | MP0002998_abnormal_bone_remodeling | 0.76520967 |
85 | MP0003183_abnormal_peptide_metabolism | 0.76450943 |
86 | MP0008058_abnormal_DNA_repair | 0.75875008 |
87 | MP0004782_abnormal_surfactant_physiolog | 0.75794848 |
88 | MP0003045_fibrosis | 0.75397657 |
89 | MP0008004_abnormal_stomach_pH | 0.75246963 |
90 | MP0009763_increased_sensitivity_to | 0.75176255 |
91 | MP0005390_skeleton_phenotype | 0.74027414 |
92 | MP0002009_preneoplasia | 0.71862257 |
93 | MP0008057_abnormal_DNA_replication | 0.71378518 |
94 | MP0010307_abnormal_tumor_latency | 0.69859752 |
95 | MP0003075_altered_response_to | 0.69634774 |
96 | MP0003279_aneurysm | 0.69445793 |
97 | MP0001663_abnormal_digestive_system | 0.68615315 |
98 | MP0003566_abnormal_cell_adhesion | 0.65044796 |
99 | MP0000015_abnormal_ear_pigmentation | 0.65014071 |
100 | MP0002277_abnormal_respiratory_mucosa | 0.64269593 |
101 | MP0000604_amyloidosis | 0.63896319 |
102 | MP0000313_abnormal_cell_death | 0.62937115 |
103 | MP0002254_reproductive_system_inflammat | 0.61301112 |
104 | MP0005166_decreased_susceptibility_to | 0.59758880 |
105 | MP0001879_abnormal_lymphatic_vessel | 0.59492282 |
106 | MP0009765_abnormal_xenobiotic_induced | 0.59276008 |
107 | MP0003795_abnormal_bone_structure | 0.58727155 |
108 | MP0005083_abnormal_biliary_tract | 0.58348849 |
109 | MP0005275_abnormal_skin_tensile | 0.58334461 |
110 | MP0000477_abnormal_intestine_morphology | 0.57504698 |
111 | MP0003943_abnormal_hepatobiliary_system | 0.57269734 |
112 | MP0008873_increased_physiological_sensi | 0.56780296 |
113 | MP0001348_abnormal_lacrimal_gland | 0.56626511 |
114 | MP0010368_abnormal_lymphatic_system | 0.56430227 |
115 | MP0002132_abnormal_respiratory_system | 0.55915328 |
116 | MP0000371_diluted_coat_color | 0.54906452 |
117 | MP0002133_abnormal_respiratory_system | 0.54090476 |
118 | MP0009840_abnormal_foam_cell | 0.51504924 |
119 | MP0002136_abnormal_kidney_physiology | 0.51359303 |
120 | MP0003091_abnormal_cell_migration | 0.50661031 |
121 | MP0000767_abnormal_smooth_muscle | 0.50286571 |
122 | MP0004957_abnormal_blastocyst_morpholog | 0.46832412 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * Elevated erythrocyte sedimentation rate (HP:0003565) | 4.92148774 |
2 | Recurrent abscess formation (HP:0002722) | 4.85250057 |
3 | Chronic otitis media (HP:0000389) | 4.73537152 |
4 | IgM deficiency (HP:0002850) | 4.61505005 |
5 | Recurrent bacterial skin infections (HP:0005406) | 4.37066235 |
6 | Eczematoid dermatitis (HP:0000976) | 4.33557957 |
7 | * Myositis (HP:0100614) | 4.32497985 |
8 | Recurrent bronchitis (HP:0002837) | 4.26642786 |
9 | Recurrent viral infections (HP:0004429) | 3.93457401 |
10 | Recurrent fungal infections (HP:0002841) | 3.82532685 |
11 | Panhypogammaglobulinemia (HP:0003139) | 3.56092525 |
12 | Abnormality of T cell physiology (HP:0011840) | 3.55028795 |
13 | Orchitis (HP:0100796) | 3.52839863 |
14 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.48957703 |
15 | Meningitis (HP:0001287) | 3.47916401 |
16 | Recurrent skin infections (HP:0001581) | 3.43637528 |
17 | Recurrent cutaneous fungal infections (HP:0011370) | 3.40203042 |
18 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.40203042 |
19 | Abnormality of T cells (HP:0002843) | 3.39983091 |
20 | Nasal polyposis (HP:0100582) | 3.33682800 |
21 | Agammaglobulinemia (HP:0004432) | 3.30226157 |
22 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.27406213 |
23 | Absent/shortened dynein arms (HP:0200106) | 3.27406213 |
24 | * Thrombocytosis (HP:0001894) | 3.27372191 |
25 | Optic neuritis (HP:0100653) | 3.26139100 |
26 | Retrobulbar optic neuritis (HP:0100654) | 3.26139100 |
27 | Abnormality of B cell number (HP:0010975) | 3.25859116 |
28 | B lymphocytopenia (HP:0010976) | 3.25859116 |
29 | Vasculitis (HP:0002633) | 3.24606023 |
30 | Inflammation of the large intestine (HP:0002037) | 3.23917828 |
31 | Abnormality of the nasal mucosa (HP:0000433) | 3.23355331 |
32 | Cellulitis (HP:0100658) | 3.22110658 |
33 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.17679286 |
34 | Gastrointestinal inflammation (HP:0004386) | 3.16394257 |
35 | Pustule (HP:0200039) | 3.11805904 |
36 | Colitis (HP:0002583) | 3.08215571 |
37 | Mediastinal lymphadenopathy (HP:0100721) | 3.07584408 |
38 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.02456798 |
39 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.02456798 |
40 | Abnormality of macrophages (HP:0004311) | 3.01474886 |
41 | Petechiae (HP:0000967) | 2.99720772 |
42 | Obstructive lung disease (HP:0006536) | 2.96003368 |
43 | Chronic obstructive pulmonary disease (HP:0006510) | 2.96003368 |
44 | IgG deficiency (HP:0004315) | 2.95515355 |
45 | Autoimmune thrombocytopenia (HP:0001973) | 2.94521349 |
46 | Abnormality of T cell number (HP:0011839) | 2.93394558 |
47 | Lymphopenia (HP:0001888) | 2.92608431 |
48 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.89222522 |
49 | Gastrointestinal stroma tumor (HP:0100723) | 2.88896129 |
50 | Spontaneous hematomas (HP:0007420) | 2.86781175 |
51 | T lymphocytopenia (HP:0005403) | 2.85869642 |
52 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.81251566 |
53 | Abnormal ciliary motility (HP:0012262) | 2.79249831 |
54 | Chronic diarrhea (HP:0002028) | 2.72384269 |
55 | Eosinophilia (HP:0001880) | 2.71634078 |
56 | Systemic lupus erythematosus (HP:0002725) | 2.66770480 |
57 | Aplastic anemia (HP:0001915) | 2.61803056 |
58 | IgA deficiency (HP:0002720) | 2.61765226 |
59 | Chronic sinusitis (HP:0011109) | 2.59233418 |
60 | Granulocytopenia (HP:0001913) | 2.58882125 |
61 | Leukocytosis (HP:0001974) | 2.58046603 |
62 | Hematochezia (HP:0002573) | 2.56840362 |
63 | Emphysema (HP:0002097) | 2.55458311 |
64 | Pulmonary infiltrates (HP:0002113) | 2.55183161 |
65 | Recurrent sinusitis (HP:0011108) | 2.53490392 |
66 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.52897519 |
67 | Stomatitis (HP:0010280) | 2.50795199 |
68 | Vacuolated lymphocytes (HP:0001922) | 2.50656469 |
69 | Autoimmune hemolytic anemia (HP:0001890) | 2.49387172 |
70 | Arterial thrombosis (HP:0004420) | 2.47695270 |
71 | Hemoptysis (HP:0002105) | 2.46963194 |
72 | Encephalitis (HP:0002383) | 2.44688109 |
73 | Abnormality of eosinophils (HP:0001879) | 2.42964551 |
74 | Lymphoma (HP:0002665) | 2.42236278 |
75 | Keratoconjunctivitis (HP:0001096) | 2.40001297 |
76 | Thyroiditis (HP:0100646) | 2.38503132 |
77 | Keratoconjunctivitis sicca (HP:0001097) | 2.38398964 |
78 | Gastrointestinal infarctions (HP:0005244) | 2.37608601 |
79 | Bronchiectasis (HP:0002110) | 2.36699387 |
80 | Polygenic inheritance (HP:0010982) | 2.34599244 |
81 | Amyloidosis (HP:0011034) | 2.34084148 |
82 | Severe combined immunodeficiency (HP:0004430) | 2.33752248 |
83 | Reticulocytopenia (HP:0001896) | 2.32776711 |
84 | Recurrent pneumonia (HP:0006532) | 2.32407304 |
85 | Abnormality of the fingertips (HP:0001211) | 2.31046881 |
86 | Basal ganglia calcification (HP:0002135) | 2.31037593 |
87 | Hypertensive crisis (HP:0100735) | 2.30731695 |
88 | Spondylolisthesis (HP:0003302) | 2.29883004 |
89 | Osteomyelitis (HP:0002754) | 2.27750223 |
90 | Recurrent lower respiratory tract infections (HP:0002783) | 2.25558490 |
91 | Increased serum ferritin (HP:0003281) | 2.23444209 |
92 | Chest pain (HP:0100749) | 2.22806962 |
93 | Increased IgE level (HP:0003212) | 2.22285750 |
94 | Bronchitis (HP:0012387) | 2.22256482 |
95 | Rhinitis (HP:0012384) | 2.21338388 |
96 | Skin ulcer (HP:0200042) | 2.21056844 |
97 | Epistaxis (HP:0000421) | 2.19971911 |
98 | Combined immunodeficiency (HP:0005387) | 2.18226829 |
99 | Periodontitis (HP:0000704) | 2.16012558 |
100 | Prolonged bleeding time (HP:0003010) | 2.15842551 |
101 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.13192575 |
102 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.13192575 |
103 | Abnormality of glycolipid metabolism (HP:0010969) | 2.13192575 |
104 | Increased IgM level (HP:0003496) | 2.12950826 |
105 | * Hypergammaglobulinemia (HP:0010702) | 2.10557737 |
106 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.04213848 |
107 | Episodic fever (HP:0001954) | 2.04025142 |
108 | Increased cerebral lipofuscin (HP:0011813) | 2.02185554 |
109 | Dysostosis multiplex (HP:0000943) | 2.01797778 |
110 | Abnormality of the prostate (HP:0008775) | 1.99580196 |
111 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.99496089 |
112 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.99496089 |
113 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.99496089 |
114 | Aortic aneurysm (HP:0004942) | 1.99295925 |
115 | Protrusio acetabuli (HP:0003179) | 1.98915189 |
116 | Abnormality of iron homeostasis (HP:0011031) | 1.97520777 |
117 | Reduced antithrombin III activity (HP:0001976) | 1.97444572 |
118 | Polycythemia (HP:0001901) | 1.95966255 |
119 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.95414287 |
120 | Mucopolysacchariduria (HP:0008155) | 1.95414287 |
121 | Purpura (HP:0000979) | 1.94046244 |
122 | Hepatosplenomegaly (HP:0001433) | 1.93762585 |
123 | Gingival bleeding (HP:0000225) | 1.93556617 |
124 | Abnormality of the pleura (HP:0002103) | 1.93519049 |
125 | Urticaria (HP:0001025) | 1.91475667 |
126 | Gingivitis (HP:0000230) | 1.90858369 |
127 | Verrucae (HP:0200043) | 1.90673287 |
128 | Papilloma (HP:0012740) | 1.90673287 |
129 | Abnormal platelet function (HP:0011869) | 1.90462181 |
130 | Impaired platelet aggregation (HP:0003540) | 1.90462181 |
131 | Restrictive lung disease (HP:0002091) | 1.90442062 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 4.36651767 |
2 | KIT | 3.15483212 |
3 | BLK | 2.95396846 |
4 | TYK2 | 2.78445845 |
5 | TXK | 2.73213851 |
6 | JAK3 | 2.65106415 |
7 | TGFBR2 | 2.53084571 |
8 | CSF1R | 2.51666137 |
9 | MAP3K14 | 2.37029714 |
10 | ZAP70 | 2.35730755 |
11 | TEC | 2.28805344 |
12 | IRAK4 | 2.25725036 |
13 | FLT3 | 2.21934348 |
14 | NME2 | 2.19597973 |
15 | PRPF4B | 2.18110651 |
16 | MAPK15 | 2.10197641 |
17 | IKBKE | 2.06065254 |
18 | EEF2K | 2.03115688 |
19 | BTK | 2.01712404 |
20 | * TBK1 | 1.94368831 |
21 | ERN1 | 1.87409841 |
22 | SYK | 1.72594267 |
23 | STK10 | 1.70732205 |
24 | PIM2 | 1.68080559 |
25 | ITK | 1.66987459 |
26 | CLK1 | 1.64543142 |
27 | KDR | 1.63865572 |
28 | JAK1 | 1.59015965 |
29 | IKBKB | 1.55306493 |
30 | TGFBR1 | 1.52066419 |
31 | MAP3K3 | 1.49316569 |
32 | RIPK4 | 1.45316315 |
33 | MAP2K3 | 1.43681797 |
34 | LCK | 1.43181658 |
35 | TNK2 | 1.42880844 |
36 | LRRK2 | 1.34121995 |
37 | RPS6KA4 | 1.32109232 |
38 | MAP3K11 | 1.27580095 |
39 | IRAK3 | 1.26134496 |
40 | FGFR4 | 1.24684468 |
41 | NLK | 1.22579846 |
42 | HCK | 1.21656844 |
43 | FES | 1.19217223 |
44 | LYN | 1.17331512 |
45 | MAPK7 | 1.12626703 |
46 | CSK | 1.10464616 |
47 | TESK1 | 1.09011456 |
48 | MAP3K7 | 1.08184030 |
49 | GRK6 | 1.07487747 |
50 | PRKD2 | 1.06837562 |
51 | PKN2 | 1.05304705 |
52 | PIM1 | 1.01785141 |
53 | SMG1 | 0.98344459 |
54 | PTK2B | 0.97645556 |
55 | MAP3K13 | 0.97085764 |
56 | MAP3K10 | 0.96230205 |
57 | MYLK | 0.95312053 |
58 | TAOK2 | 0.94016947 |
59 | MAP3K6 | 0.93578662 |
60 | SCYL2 | 0.86853942 |
61 | FGFR3 | 0.86850348 |
62 | MATK | 0.84801677 |
63 | ACVR1B | 0.84467987 |
64 | TAOK3 | 0.84440150 |
65 | MAP3K1 | 0.83371507 |
66 | NEK9 | 0.81879812 |
67 | CHUK | 0.81834554 |
68 | EPHB1 | 0.78877135 |
69 | ADRBK2 | 0.78076720 |
70 | MAPK12 | 0.76606949 |
71 | MAP2K2 | 0.75183808 |
72 | PAK4 | 0.75022563 |
73 | TESK2 | 0.70340835 |
74 | MARK2 | 0.69873314 |
75 | TSSK6 | 0.68324010 |
76 | TRIB3 | 0.67868559 |
77 | EIF2AK3 | 0.67849518 |
78 | JAK2 | 0.67794109 |
79 | RPS6KB2 | 0.67215854 |
80 | MST4 | 0.64033860 |
81 | CAMKK2 | 0.63049232 |
82 | TAOK1 | 0.62565467 |
83 | BCKDK | 0.62411556 |
84 | SIK3 | 0.61452822 |
85 | GRK7 | 0.61212967 |
86 | TRPM7 | 0.59618455 |
87 | BMPR2 | 0.58569434 |
88 | MAPKAPK3 | 0.58414167 |
89 | EIF2AK1 | 0.57834690 |
90 | VRK1 | 0.57475453 |
91 | CDC42BPA | 0.54255471 |
92 | TTN | 0.52538125 |
93 | CDK4 | 0.52436220 |
94 | PDPK1 | 0.52117241 |
95 | STK4 | 0.51703544 |
96 | NEK2 | 0.50503058 |
97 | MOS | 0.49704977 |
98 | PRKG2 | 0.48775685 |
99 | MAPKAPK2 | 0.46951838 |
100 | MAP3K12 | 0.46502563 |
101 | CDK8 | 0.46020645 |
102 | DYRK3 | 0.45594560 |
103 | EPHA3 | 0.45060492 |
104 | CDK6 | 0.44442281 |
105 | MAP3K8 | 0.43519215 |
106 | EIF2AK2 | 0.43327261 |
107 | RPS6KA2 | 0.43240631 |
108 | MARK3 | 0.42646991 |
109 | STK38 | 0.42547089 |
110 | TIE1 | 0.42208624 |
111 | PIK3CG | 0.42097920 |
112 | RPS6KA6 | 0.41454032 |
113 | MAPK4 | 0.41002809 |
114 | DAPK1 | 0.39612049 |
115 | MAPK3 | 0.39037270 |
116 | FYN | 0.38859777 |
117 | ATR | 0.38364570 |
118 | MAPK11 | 0.37551252 |
119 | PTK6 | 0.36908464 |
120 | WEE1 | 0.36887174 |
121 | IRAK1 | 0.36411597 |
122 | SIK1 | 0.35722239 |
123 | PRKD1 | 0.35465698 |
124 | HIPK2 | 0.35199856 |
125 | SIK2 | 0.34913739 |
126 | TLK1 | 0.32520880 |
127 | PRKCD | 0.31244169 |
128 | PRKCQ | 0.30920061 |
129 | STK16 | 0.30487137 |
130 | ABL1 | 0.30355587 |
131 | MAP2K6 | 0.28946014 |
132 | RPS6KL1 | 0.28735889 |
133 | RPS6KC1 | 0.28735889 |
134 | BRSK2 | 0.28611245 |
135 | PDK1 | 0.27021054 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.61942823 |
2 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.58190228 |
3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.55632685 |
4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.42554324 |
5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.34441743 |
6 | Measles_Homo sapiens_hsa05162 | 2.34039100 |
7 | DNA replication_Homo sapiens_hsa03030 | 2.29633545 |
8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.25296584 |
9 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.16390413 |
10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.08808956 |
11 | * Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.04236341 |
12 | Allograft rejection_Homo sapiens_hsa05330 | 2.01171991 |
13 | Ribosome_Homo sapiens_hsa03010 | 1.96816985 |
14 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.90938249 |
15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.89718666 |
16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.85268886 |
17 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.80203708 |
18 | * RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.72549630 |
19 | Legionellosis_Homo sapiens_hsa05134 | 1.67276254 |
20 | Other glycan degradation_Homo sapiens_hsa00511 | 1.65883465 |
21 | Base excision repair_Homo sapiens_hsa03410 | 1.62607317 |
22 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.62433434 |
23 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.61767814 |
24 | Pertussis_Homo sapiens_hsa05133 | 1.60849762 |
25 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.59309060 |
26 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.55879623 |
27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.52662502 |
28 | Malaria_Homo sapiens_hsa05144 | 1.50201114 |
29 | Influenza A_Homo sapiens_hsa05164 | 1.49461865 |
30 | Mismatch repair_Homo sapiens_hsa03430 | 1.45878173 |
31 | Shigellosis_Homo sapiens_hsa05131 | 1.45298799 |
32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.41202605 |
33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.38633325 |
34 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.38134381 |
35 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.36552997 |
36 | Tuberculosis_Homo sapiens_hsa05152 | 1.29920403 |
37 | Apoptosis_Homo sapiens_hsa04210 | 1.29913299 |
38 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.29774905 |
39 | Viral myocarditis_Homo sapiens_hsa05416 | 1.29698351 |
40 | Hepatitis B_Homo sapiens_hsa05161 | 1.28254097 |
41 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.23668770 |
42 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.22699151 |
43 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.17999989 |
44 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.11971273 |
45 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.08382460 |
46 | Salmonella infection_Homo sapiens_hsa05132 | 1.08251767 |
47 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.08230328 |
48 | Homologous recombination_Homo sapiens_hsa03440 | 1.04882442 |
49 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.04559620 |
50 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.01135881 |
51 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.01024030 |
52 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.00452075 |
53 | Asthma_Homo sapiens_hsa05310 | 0.99479648 |
54 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.98161500 |
55 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.95238088 |
56 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.92217957 |
57 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.90884174 |
58 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.90646055 |
59 | Lysosome_Homo sapiens_hsa04142 | 0.90350938 |
60 | Platelet activation_Homo sapiens_hsa04611 | 0.89325145 |
61 | Proteasome_Homo sapiens_hsa03050 | 0.88940106 |
62 | HTLV-I infection_Homo sapiens_hsa05166 | 0.87500728 |
63 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.87200666 |
64 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.84434117 |
65 | Spliceosome_Homo sapiens_hsa03040 | 0.84337538 |
66 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.84160325 |
67 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.83195151 |
68 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.82744026 |
69 | Hepatitis C_Homo sapiens_hsa05160 | 0.79354254 |
70 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.75459529 |
71 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.74304253 |
72 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.72934544 |
73 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.72366806 |
74 | Protein export_Homo sapiens_hsa03060 | 0.65270428 |
75 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.64933346 |
76 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.64598183 |
77 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.64371066 |
78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.63738186 |
79 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.63523463 |
80 | Endocytosis_Homo sapiens_hsa04144 | 0.61097562 |
81 | Cell cycle_Homo sapiens_hsa04110 | 0.58561152 |
82 | Colorectal cancer_Homo sapiens_hsa05210 | 0.58043664 |
83 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.57846883 |
84 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.54672988 |
85 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.53435205 |
86 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.53018380 |
87 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.51090393 |
88 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50770896 |
89 | Phagosome_Homo sapiens_hsa04145 | 0.49252315 |
90 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.48342920 |
91 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.48071414 |
92 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.47095723 |
93 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.45334605 |
94 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.44685517 |
95 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.44631656 |
96 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.43204333 |
97 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.43173195 |
98 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.43077750 |
99 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.43023595 |
100 | RNA degradation_Homo sapiens_hsa03018 | 0.42998615 |
101 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.41822650 |
102 | Insulin resistance_Homo sapiens_hsa04931 | 0.41219542 |
103 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.39437632 |
104 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.39194870 |
105 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.38312396 |
106 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.37937353 |
107 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.37636580 |
108 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.37621158 |
109 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.37046359 |
110 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.35764714 |
111 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.35275162 |
112 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.33118995 |
113 | Thyroid cancer_Homo sapiens_hsa05216 | 0.32960712 |
114 | Focal adhesion_Homo sapiens_hsa04510 | 0.32956482 |
115 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.32760186 |
116 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.32039613 |
117 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.31236221 |
118 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.30922654 |
119 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.29983094 |
120 | Amoebiasis_Homo sapiens_hsa05146 | 0.28867963 |
121 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.28322817 |
122 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.26606594 |
123 | Bladder cancer_Homo sapiens_hsa05219 | 0.26012849 |
124 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.25981356 |
125 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.22358395 |
126 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.20583250 |
127 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.19206369 |